AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 281: H959-H968, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kodani, E.
Right arrow Articles by Bolli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kodani, E.
Right arrow Articles by Bolli, R.
Vol. 281, Issue 2, H959-H968, August 2001

Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors

Eitaro Kodani, Ken Shinmura, Yu-Ting Xuan, Hitoshi Takano, John A. Auchampach, Xian-Liang Tang, and Roberto Bolli

Experimental Research Laboratory, Division of Cardiology, University of Louisville and Jewish Heart and Lung Institute, Louisville, Kentucky 40292

Recent studies have demonstrated that the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA) and the adenosine A3 receptor agonist N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) produce a delayed phase of protection against infarction similar to the late phase of ischemic preconditioning (PC). However, the mechanism for adenosine A1 or A3 receptor-induced late PC remains unknown. The goal of this study was to determine whether the delayed cardioprotective effects of adenosine A1 or A3 receptors are mediated by cyclooxygenase-2 (COX-2), which is an obligatory mediator of ischemic PC. We found that COX-2 protein expression (Western blotting) did not increase 24 h after the administration of either CCPA (100 µg/kg iv) or IB-MECA (300 µg/kg iv) compared with controls. To probe the role of constitutive COX-2 expression, conscious rabbits were subjected to 30-min coronary occlusion followed by 72-h reperfusion. Twenty-four hours before the occlusion, the rabbits were pretreated with CCPA (100 µg/kg iv) or IB-MECA (300 µg/kg iv). Both CCPA and IB-MECA resulted in a marked (~47%) reduction in infarct size vs. controls [36.2 ± 4.0% of the risk region (n = 9), 31.2 ± 4.7% (n = 9), and 59.5 ± 3.8% (n = 9), respectively; P < 0.05], similar to that induced by the late phase of ischemic PC [31.8 ± 3.2% (n = 9)]. The selective COX-2 inhibitor N-(2-[cyclohexyloxy]4-nitrophenyl)methanesulfonamide (NS-398, 5 mg/kg), which abolished the protective effect of ischemic late PC, failed to block the protection of either CCPA or IB-MECA, indicating that COX-2 does not mediate the delayed protection of either CCPA or IB-MECA [CCPA + NS-398, 29.1 ± 3.4% (n = 7); IB-MECA + NS-398, 34.9 ± 2.9% (n = 8)]. NS-398 in itself did not affect infarct size [54.9 ± 3.7% (n = 9)]. Taken together, these results demonstrate that, in contrast to ischemia-induced late PC, the mechanisms of adenosine A1 or A3 receptor-induced late PC is independent of COX-2.

myocardial ischemia; myocardial reperfusion; 2-chloro- N6-cyclopentyl-adenosine; N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide; NS-398


This article has been cited by other articles:


Home page
 Card Surg AdultHome page
R. M. Mentzer Jr, M. S. Jahania, and R. D. Lasley
Myocardial Protection
Card. Surg. Adult, January 1, 2008; 3(2008): 443 - 464.
[Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Birkenmeier, A. Staudt, W.-H. Schunck, I. Janke, C. Labitzke, T. Prange, C. Trimpert, T. Krieg, M. Landsberger, V. Stangl, et al.
COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2148 - H2154.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. D. Lasley, B. J. Keith, G. Kristo, Y. Yoshimura, and R. M. Mentzer Jr.
Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H785 - H791.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
X. Jiang, E. Shi, Y. Nakajima, S. Sato, K. Ohno, and H. Yue
Cyclooxygenase-1 Mediates the Final Stage of Morphine-Induced Delayed Cardioprotection in Concert With Cyclooxygenase-2
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1707 - 1715.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X.-L. Tang, Y.-T. Xuan, Y. Zhu, G. Shirk, and R. Bolli
Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1273 - H1280.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Auchampach, Z.-D. Ge, T. C. Wan, J. Moore, and G. J. Gross
A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H607 - H613.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X.-L. Tang, E. Kodani, H. Takano, M. Hill, K. Shinmura, T. M. Vondriska, P. Ping, and R. Bolli
Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1441 - H1448.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, M. Nagai, K. Tamaki, M. Tani, and R. Bolli
COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2534 - H2543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. Kodani, Y.-T. Xuan, K. Shinmura, H. Takano, X.-L. Tang, and R. Bolli
delta -Opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1943 - H1957.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G.F Baxter
Role of adenosine in delayed preconditioning of myocardium
Cardiovasc Res, August 15, 2002; 55(3): 483 - 494.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Bolli, K. Shinmura, X.-L. Tang, E. Kodani, Y.-T. Xuan, Y. Guo, and B. Dawn
Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 506 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kudo, Y. Wang, M. Xu, A. Ayub, and M. Ashraf
Adenosine A1 receptor mediates late preconditioning via activation of PKC-delta signaling pathway
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H296 - H301.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Xi, D. Tekin, E. Gursoy, F. Salloum, J. E. Levasseur, and R. C. Kukreja
Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H5 - H12.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Tissier, R. Souktani, P. Bruneval, J.-F. Giudicelli, A. Berdeaux, and B. Ghaleh
Adenosine A1-receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H38 - H43.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online